Clinical Trials Directory

Trials / Completed

CompletedNCT02851498

Use of Novel High-protein Food Products To Reduce Insulin Resistance

Use of Novel High-protein Food Products to Reduce Insulin Resistance in Adults With an Elevated Triglyceride/HDL Ratio

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
39 (actual)
Sponsor
Arizona State University · Academic / Other
Sex
All
Age
20 Years – 75 Years
Healthy volunteers
Accepted

Summary

This controlled weight loss trial in adults at cardiometabolic risk (elevated triglyceride/HDL ratio) followed a randomized, cross-over design and utilized novel, high-protein pasta and cereal to examine the physiological impact of stealth substitution of dietary carbohydrate with protein derived from soy concentrates, wheat protein isolates, and dried egg whites. Pasta dishes were prepared using high-protein orzo and fusilli pasta (Zone PastaRxTM) or conventional, gluten-free pasta, and high-protein flaked cereal (ZoneTM cereal) was matched with conventional flaked cereal. Participants were instructed to follow an energy restricted diet (-500 kcal/d) and incorporate a test food into each of three meals over a 24-hour period. The diet-induced changes in body mass and lean body mass were tracked as well as changes in in insulin sensitivity and common blood biomarkers.

Conditions

Interventions

TypeNameDescription
OTHERFood product: high-protein pasta and cereal

Timeline

Start date
2015-01-01
Primary completion
2015-12-01
Completion
2016-09-01
First posted
2016-08-01
Last updated
2019-08-28

Source: ClinicalTrials.gov record NCT02851498. Inclusion in this directory is not an endorsement.